Open AccessPreparation, Pharmacokinetics, and Antitumor Potential of Miltefosine-Loaded Nanostructured Lipid Carriers
Author(s) -
Yu Guo,
Zameer Ali,
Anam Khan,
Kalim Ullah,
Humzah Jamshaid,
Alam Zeb,
Muhammad Imran,
Sadia Sarwar,
HanGon Choi,
Fakhar ud Din
Publication year - 2021
Publication title -
international journal of nanomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.245
H-Index - 128
eISSN - 1178-2013
pISSN - 1176-9114
DOI - 10.2147/ijn.s299443
Subject(s) - in vivo , pharmacology , pharmacokinetics , miltefosine , biodistribution , chemistry , drug carrier , in vitro , drug , medicine , biochemistry , biology , immunology , microbiology and biotechnology , leishmaniasis , visceral leishmaniasis
The purpose of this study was to investigate the suitability of nanostructured lipid carriers (NLCs) loaded with miltefosine (HePC) as an anticancer drug for the treatment of breast cancer.